Medical Procedures Could Transmit Alzheimerās Disease, Study Suggests
Alzheimerās disease, the most common form of dementia, has long been a mysterious condition with unknown causes. However, a recent study has suggested that the disease could be transmitted through certain medical procedures. The results of studies on preclinical models have shown that Alzheimerās may be a consequence of bone marrow stem cell transplants.
Researchers observed that stem cells from engineered mice, carrying a genetic mutation associated with Alzheimerās, could cause rapid development of cognitive decline and pathological features of the disease when transplanted into healthy mice. These findings were published in the journal Stem Cell Reports.
The risk of iatrogenic diseases, those that arise as a result of medical procedures, is rare but has become a growing concern, especially with conditions like Alzheimerās where the causes are not fully understood. The genetic anomalies associated with Alzheimerās, particularly related to a protein called amyloid beta precursor, could potentially be transmitted through certain medical procedures.
The study highlights the importance of considering the potential transmission of Alzheimerās through medical procedures and the need for genomic sequencing of donor samples before tissue, organ, or stem cell transplants. This research sheds new light on the possibility of iatrogenic transmission of Alzheimerās and calls for further precautions in medical procedures to mitigate this risk.